Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Comment by topseekeron Jul 30, 2020 12:19pm
180 Views
Post# 31344362

RE:Recruitment Issues

RE:Recruitment Issues
Justforfun10 wrote: If we are having difficulty recruiting patients for the trial in Florida of all places then that doesn't bode well for AGN. Maybe a little too late in the game waiting 3 months for any of our trials to start while other treatment trials ongoing. Perhaps most patients prefer to get or wait for Remdesivir availability or an anti viral.


 From start to finish with your statements, it appears you didn't catch all the recent interviews, NRs and most importantly, covid 19 didn't really start picking up til March. It's very clearly stated the issues of setting up trials in hospitals. No matter your size. 

 AGN just sitting around ? And doing... what ? They already have 5 institutes lined up for the trials.

 How readily avail. do you think Remdesivir is ? The patient has time to think/decide/has choices ? He/She has basically 2 weeks from start to finish, and the finish could very well be death or a lifetime of lung and or other organ damage.

 The Ifendropil has been in use for decades and effects are well documented. I've read that you may get a headache. Oh well, let me think, a possible headache vs possible death or possible lifetime organ issues ?

 Looking at the trading action, day after day, Mr/Ms Anon is in full swing trying to squeeze out a dollar or two from all us Longs.

 Best wishes to All, good health,

 Sincerely,

 Topseeker

Bullboard Posts